China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production...
China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production...